A drug that could reduce the risk of death in cancer patients is showing good promise during its second phase of clinical ...

In comparison, at its current levels of around $195, AbbVie stock trades at 18x expected 2024 earnings of $10.88 per share. This compares with the 12x average P/E multiple for ABBV seen over the last ...

DeepWell co-founder Ryan Douglas says the device developer and its partners have broken through the major challenges of ...

As is often the case with investing (and in life), a new player has entered the telemedicine arena: Hims & Hers Health (NYSE: ...

The drugmaker’s fastest-growing blockbuster could soon face competition from two biotech firms in the treatment of a ...

The company joins Eli Lilly in offering its own digital platform to more directly connect to patients, allowing them easier access to healthcare providers and prescription drugs.

Cantor Fitzgerald analyst Louise Chen maintained a Buy rating on Johnson & Johnson (JNJ – Research Report) today and set a price ...

Report on how AI is driving market transformation- The global menstrual drugs market size is estimated to grow by US ...

To start, according to Pfizer’s launch announcement Tuesday ... via the digitally powered Alto Pharmacy and purchase over-the-counter tests and treatments for COVID, flu and more via grocery ...

The global Over The Counter Pain Medication Market Size to Grow from USD 27.12 Billion in 2024 to USD 35.50 Billion by 2031, ...